Early propylactic factor replacement therapy can prevent chronic complications of severe hemophilia such as arthropathy. With prophylaxis life expectancy is close to normal and the quality of life as well.
The journal Annals of Blood published in their January issue of 2018 the article Von Willebrand disease - the Nordic perspective. The article was written by six members of the Nordic Hemophilia Council, on behalf of the council.
Helsinki, 31 August - 2 September